03Dec 2022
Age‐dependent prevalence of type 2 diabetes, cardiovascular risk profiles, and use of diabetes drugs in Germany using health claims data

Age‐dependent prevalence of type 2 diabetes, cardiovascular risk profiles, and use of diabetes drugs in Germany using health claims data

This study evaluates type 2 diabetes mellitus (T2DM) prevalence in Germany, focussing on patients at risk for, or with already established, cardiovascular disease (CVD), as well as their antidiabetic and cardiovascular treatments. T2DM is widespread and affects older patients particularly. Most T2DM patients had at least one CV risk factor, and around half already had established CVD. Early prevention of CVD, which disproportionately affects patients with T2DM, is necessary. Furthermore, treatment of older T2DM patients with insulin is still common and needs further evaluation.

  • #endo-diabetology

Like

Save

Share